Lazard Asset Management
SUPN icon

Lazard Asset Management’s Supernus Pharmaceuticals SUPN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$3.51M Buy
111,399
+88,881
+395% +$2.8M ﹤0.01% 837
2025
Q1
$737K Buy
22,518
+19,631
+680% +$643K ﹤0.01% 1308
2024
Q4
$104K Sell
2,887
-115
-4% -$4.14K ﹤0.01% 1791
2024
Q3
$93K Buy
3,002
+797
+36% +$24.7K ﹤0.01% 1791
2024
Q2
$58K Sell
2,205
-23
-1% -$605 ﹤0.01% 1903
2024
Q1
$75K Sell
2,228
-9,753
-81% -$328K ﹤0.01% 1624
2023
Q4
$346K Buy
11,981
+76
+0.6% +$2.2K ﹤0.01% 1214
2023
Q3
$327K Buy
11,905
+7,508
+171% +$206K ﹤0.01% 1252
2023
Q2
$132K Buy
+4,397
New +$132K ﹤0.01% 1475
2023
Q1
Sell
-1,748
Closed -$62K 2545
2022
Q4
$62K Hold
1,748
﹤0.01% 1710
2022
Q3
$59K Sell
1,748
-1,750
-50% -$59.1K ﹤0.01% 1729
2022
Q2
$101K Buy
3,498
+1,460
+72% +$42.2K ﹤0.01% 1504
2022
Q1
$65K Buy
2,038
+14
+0.7% +$447 ﹤0.01% 1615
2021
Q4
$59K Buy
2,024
+274
+16% +$7.99K ﹤0.01% 1663
2021
Q3
$46K Sell
1,750
-180
-9% -$4.73K ﹤0.01% 1719
2021
Q2
$59K Hold
1,930
﹤0.01% 1534
2021
Q1
$50K Buy
+1,930
New +$50K ﹤0.01% 1436
2020
Q4
Sell
-2,461
Closed -$51K 1980
2020
Q3
$51K Buy
+2,461
New +$51K ﹤0.01% 1180
2020
Q1
Sell
-2,284
Closed -$54K 1741
2019
Q4
$54K Buy
2,284
+1,821
+393% +$43.1K ﹤0.01% 1038
2019
Q3
$12K Buy
+463
New +$12K ﹤0.01% 1273
2018
Q3
Sell
-33,650
Closed -$2.01M 1105
2018
Q2
$2.01M Hold
33,650
﹤0.01% 660
2018
Q1
$1.54M Sell
33,650
-1,500
-4% -$68.7K ﹤0.01% 673
2017
Q4
$1.4M Sell
35,150
-18,500
-34% -$737K ﹤0.01% 666
2017
Q3
$2.15M Sell
53,650
-10,200
-16% -$408K ﹤0.01% 622
2017
Q2
$2.75M Sell
63,850
-2,200
-3% -$94.8K 0.01% 594
2017
Q1
$2.07M Sell
66,050
-77,250
-54% -$2.42M ﹤0.01% 652
2016
Q4
$3.62M Hold
143,300
0.01% 561
2016
Q3
$3.54M Hold
143,300
0.01% 564
2016
Q2
$2.92M Buy
+143,300
New +$2.92M 0.01% 578